Sign in to fuzzto save your conversations, follow your research and come back anytime.
Symbiotec Pharmalab
| Metric (₹ crore) | Q1 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|
| Sales | 203.17 | 245.25 | 218.15 |
| Expenses | 145.21 | 183.16 | 172.95 |
| EBITDA | 57.96 | 62.09 | 45.2 |
| Depreciation | 10.51 | 19.75 | 21.82 |
| EBIT | 47.45 | 42.34 | 23.38 |
| Interest | 5.28 | 7.26 | 6.18 |
| Profit Before Tax | 42.17 | 35.08 | 17.2 |
| Net Profit | 29.92 | 27.53 | 14.06 |
| EPS | 5.37 | 4.78 | 2.24 |
| Metric (₹ crore) | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 174.33 | 17.71 | 69.24 | 187.5 | 47.26 | 174.59 |
| Investing Cash Flow | -96.35 | -31.64 | -219.99 | -206.41 | -306.52 | -226.93 |
| Financing Cash Flow | -79.28 | 15.14 | 146.14 | 21.85 | 278.16 | 35.99 |
| Net Cash Flow | -1.3 | 1.21 | -4.61 | 2.94 | 18.9 | -16.35 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 397 | 520.57 | 598.59 | 621.44 | 714.85 | 814.7 | 1,149.59 |
| Total Liabilities | 281.69 | 247.73 | 216.58 | 368.55 | 579.94 | 764.95 | 631.2 |
| Total Assets | 678.68 | 768.3 | 815.18 | 989.99 | 1,294.79 | 1,579.65 | 1,780.79 |